NEW YORK (GenomeWeb News) – MDxHealth today reported that its first-half 2012 revenues climbed 43 percent on a sharp uptick in commercial revenues.
The Liege, Belgium-based molecular diagnostics firm reported total revenues of €2 million ($2.5 million) for the six-month period ended June 30, compared to revenues of €1.4 million for the first half of 2011.